HEADER TRANSFERASE 15-DEC-99 1C50 TITLE IDENTIFICATION AND STRUCTURAL CHARACTERIZATION OF A NOVEL ALLOSTERIC TITLE 2 BINDING SITE OF GLYCOGEN PHOSPHORYLASE B COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (GLYCOGEN PHOSPHORYLASE); COMPND 3 CHAIN: A; COMPND 4 EC: 2.4.1.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: RABBIT; SOURCE 4 ORGANISM_TAXID: 9986; SOURCE 5 TISSUE: MUSCLE KEYWDS GLYCOGEN METABOLISM, GLYCOGEN PHOSPHORYLASE B, INHIBITION, CENTRAL KEYWDS 2 CAVITY, DRUG BINDING SITE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR N.G.OIKONOMAKOS,V.T.SKAMNAKI,K.E.TSITSANOU,N.G.GAVALAS,L.N.JOHNSON REVDAT 5 27-DEC-23 1C50 1 REMARK SEQADV LINK REVDAT 4 13-JUL-11 1C50 1 VERSN REVDAT 3 24-FEB-09 1C50 1 VERSN REVDAT 2 30-AUG-00 1C50 1 JRNL REMARK REVDAT 1 23-DEC-99 1C50 0 JRNL AUTH N.G.OIKONOMAKOS,V.T.SKAMNAKI,K.E.TSITSANOU,N.G.GAVALAS, JRNL AUTH 2 L.N.JOHNSON JRNL TITL A NEW ALLOSTERIC SITE IN GLYCOGEN PHOSPHORYLASE B AS A JRNL TITL 2 TARGET FOR DRUG INTERACTIONS. JRNL REF STRUCTURE FOLD.DES. V. 8 575 2000 JRNL REFN ISSN 0969-2126 JRNL PMID 10873856 JRNL DOI 10.1016/S0969-2126(00)00144-1 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH N.G.OIKONOMAKOS,K.E.TSITSANOU,S.E.ZOGRAPHOS,V.T.SKAMNAKI, REMARK 1 AUTH 2 S.GOLDMANN,H.BISCHOFF REMARK 1 TITL ALLOSTERIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY THE REMARK 1 TITL 2 POTENTIAL ANTIDIABETIC DRUG 3-ISOPROPYL REMARK 1 TITL 3 4-(2-CHLOROPHENYL)-1,4-DIHYDRO-1-ETHYL-2-METHYL-PYRIDINE-3, REMARK 1 TITL 4 5,6-TRICARBOXYLATE REMARK 1 REF PROTEIN SCI. V. 8 1930 1999 REMARK 1 REFN ISSN 0961-8368 REMARK 1 REFERENCE 2 REMARK 1 AUTH S.E.ZOGRAPHOS,N.G.OIKONOMAKOS,K.E.TSITSANOU,D.D.LEONIDAS, REMARK 1 AUTH 2 E.D.CHRYSINA,V.T.SKAMNAKI,H.BISCHOFF,S.GOLDMANN,K.A.WATSON, REMARK 1 AUTH 3 L.N.JOHNSON REMARK 1 TITL THE STRUCTURE OF GLYCOGEN PHOSPHORYLASE B WITH AN REMARK 1 TITL 2 ALKYLDIHYDROPYRIDINE-DICARBOXYLIC ACID COMPOUND, A NOVEL AND REMARK 1 TITL 3 POTENT INHIBITOR REMARK 1 REF STRUCTURE V. 5 1413 1997 REMARK 1 REFN ISSN 0969-2126 REMARK 1 DOI 10.1016/S0969-2126(97)00292-X REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.8 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 40437 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : R FREE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6749 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 256 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.700 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.500 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.000 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 1.500 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.000 ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1C50 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-OCT-99. REMARK 100 THE DEPOSITION ID IS D_1000001313. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUL-99 REMARK 200 TEMPERATURE (KELVIN) : 287 REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 180 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42617 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.44500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PHOSPHORYLASE B-CP320626 COMPLEX WAS REMARK 280 CO-CRYSTALLISED UNDER CONDITIONS SIMILAR TO THOSE DESCRIBED BY REMARK 280 ZOGRAPHOS ET AL., (1997) STRUCTURE 5, 1413-1425., PH 6.7 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.11000 REMARK 290 SMTRY1 3 0.000000 -1.015726 0.000000 64.58700 REMARK 290 SMTRY2 3 0.984517 0.000000 0.000000 63.58700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 87.16500 REMARK 290 SMTRY1 4 0.000000 1.015726 0.000000 64.58700 REMARK 290 SMTRY2 4 -0.984517 0.000000 0.000000 63.58700 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 29.05500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 64.58700 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 63.58700 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 87.16500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 64.58700 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 63.58700 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 29.05500 REMARK 290 SMTRY1 7 0.000000 1.015726 0.000000 0.00000 REMARK 290 SMTRY2 7 0.984517 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.015726 0.000000 0.00000 REMARK 290 SMTRY2 8 -0.984517 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 58.11000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.015726 0.000000 0.00000 REMARK 350 BIOMT2 2 0.984517 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 116.22000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NE1 TRP A 174 O CYS A 318 5555 2.08 REMARK 500 O GLY A 164 O HOH A 1011 7556 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 63 CA - CB - CG ANGL. DEV. = 17.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 14 175.73 152.97 REMARK 500 VAL A 15 56.08 -95.82 REMARK 500 ALA A 19 69.56 -107.77 REMARK 500 ARG A 43 -16.60 -45.86 REMARK 500 LEU A 131 48.63 -88.90 REMARK 500 TYR A 203 -130.11 64.74 REMARK 500 SER A 210 -79.19 20.61 REMARK 500 GLN A 211 61.67 -102.36 REMARK 500 ASP A 251 -97.46 -86.19 REMARK 500 ASN A 253 48.69 -78.91 REMARK 500 LEU A 254 -36.20 165.43 REMARK 500 ASP A 256 86.59 -68.29 REMARK 500 ASN A 258 64.56 92.99 REMARK 500 VAL A 259 149.23 64.00 REMARK 500 LEU A 271 -35.17 -161.58 REMARK 500 PRO A 281 25.57 -74.29 REMARK 500 SER A 313 -66.17 -92.72 REMARK 500 SER A 314 -120.75 22.53 REMARK 500 CYS A 318 -56.43 -153.79 REMARK 500 ARG A 319 -102.86 -158.41 REMARK 500 ASP A 320 -155.60 65.11 REMARK 500 VAL A 322 106.83 61.64 REMARK 500 ARG A 323 114.71 133.69 REMARK 500 THR A 324 79.93 -49.46 REMARK 500 ASP A 339 -163.34 76.69 REMARK 500 ALA A 435 -70.46 -43.19 REMARK 500 THR A 466 -102.97 -115.84 REMARK 500 ASN A 484 171.68 -59.27 REMARK 500 LEU A 492 -75.53 -148.08 REMARK 500 ASP A 514 62.53 -164.93 REMARK 500 LYS A 554 98.68 55.57 REMARK 500 VAL A 555 31.93 167.02 REMARK 500 HIS A 556 147.80 39.43 REMARK 500 LYS A 568 173.21 174.19 REMARK 500 SER A 674 -63.64 -142.51 REMARK 500 LYS A 772 66.31 29.87 REMARK 500 PRO A 835 75.37 -48.43 REMARK 500 ALA A 836 172.98 42.36 REMARK 500 ASP A 838 113.70 -7.12 REMARK 500 GLU A 839 -93.68 1.72 REMARK 500 LYS A 840 130.96 54.93 REMARK 500 ILE A 841 86.78 -152.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: HPP REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CP320626 BINDING SITE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLP A 999 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CHI A 920 REMARK 999 REMARK 999 SEQUENCE REMARK 999 REFERENCE: K.NAKANO, P.K.HWANG, R.J.FLETTERICK, FEBS REMARK 999 LETT., V. 204, P. 283, 1986. REMARK 999 REMARK 999 HIGH RESOLUTION DATA (1.5 ANGSTROMS) REFINEMENT ON T-STATE REMARK 999 GLYCOGEN PHOSPHORYLASE (UNPUBLISHED RESULTS) HAS CONFIRMED REMARK 999 THAT RESIDUE 609 IS INDEED ALA (NOT PRO). DBREF 1C50 A 13 842 UNP P00489 PHS2_RABIT 13 842 SEQADV 1C50 ILE A 380 UNP P00489 LEU 380 CONFLICT SEQADV 1C50 ALA A 609 UNP P00489 PRO 609 SEE REMARK 999 SEQRES 1 A 830 ILE SER VAL ARG GLY LEU ALA GLY VAL GLU ASN VAL THR SEQRES 2 A 830 GLU LEU LYS LYS ASN PHE ASN ARG HIS LEU HIS PHE THR SEQRES 3 A 830 LEU VAL LYS ASP ARG ASN VAL ALA THR PRO ARG ASP TYR SEQRES 4 A 830 TYR PHE ALA LEU ALA HIS THR VAL ARG ASP HIS LEU VAL SEQRES 5 A 830 GLY ARG TRP ILE ARG THR GLN GLN HIS TYR TYR GLU LYS SEQRES 6 A 830 ASP PRO LYS ARG ILE TYR TYR LEU SER LEU GLU PHE TYR SEQRES 7 A 830 MET GLY ARG THR LEU GLN ASN THR MET VAL ASN LEU ALA SEQRES 8 A 830 LEU GLU ASN ALA CYS ASP GLU ALA THR TYR GLN LEU GLY SEQRES 9 A 830 LEU ASP MET GLU GLU LEU GLU GLU ILE GLU GLU ASP ALA SEQRES 10 A 830 GLY LEU GLY ASN GLY GLY LEU GLY ARG LEU ALA ALA CYS SEQRES 11 A 830 PHE LEU ASP SER MET ALA THR LEU GLY LEU ALA ALA TYR SEQRES 12 A 830 GLY TYR GLY ILE ARG TYR GLU PHE GLY ILE PHE ASN GLN SEQRES 13 A 830 LYS ILE CYS GLY GLY TRP GLN MET GLU GLU ALA ASP ASP SEQRES 14 A 830 TRP LEU ARG TYR GLY ASN PRO TRP GLU LYS ALA ARG PRO SEQRES 15 A 830 GLU PHE THR LEU PRO VAL HIS PHE TYR GLY ARG VAL GLU SEQRES 16 A 830 HIS THR SER GLN GLY ALA LYS TRP VAL ASP THR GLN VAL SEQRES 17 A 830 VAL LEU ALA MET PRO TYR ASP THR PRO VAL PRO GLY TYR SEQRES 18 A 830 ARG ASN ASN VAL VAL ASN THR MET ARG LEU TRP SER ALA SEQRES 19 A 830 LYS ALA PRO ASN ASP PHE ASN LEU LYS ASP PHE ASN VAL SEQRES 20 A 830 GLY GLY TYR ILE GLN ALA VAL LEU ASP ARG ASN LEU ALA SEQRES 21 A 830 GLU ASN ILE SER ARG VAL LEU TYR PRO ASN ASP ASN PHE SEQRES 22 A 830 PHE GLU GLY LYS GLU LEU ARG LEU LYS GLN GLU TYR PHE SEQRES 23 A 830 VAL VAL ALA ALA THR LEU GLN ASP ILE ILE ARG ARG PHE SEQRES 24 A 830 LYS SER SER LYS PHE GLY CYS ARG ASP PRO VAL ARG THR SEQRES 25 A 830 ASN PHE ASP ALA PHE PRO ASP LYS VAL ALA ILE GLN LEU SEQRES 26 A 830 ASN ASP THR HIS PRO SER LEU ALA ILE PRO GLU LEU MET SEQRES 27 A 830 ARG VAL LEU VAL ASP LEU GLU ARG LEU ASP TRP ASP LYS SEQRES 28 A 830 ALA TRP GLU VAL THR VAL LYS THR CYS ALA TYR THR ASN SEQRES 29 A 830 HIS THR VAL ILE PRO GLU ALA LEU GLU ARG TRP PRO VAL SEQRES 30 A 830 HIS LEU LEU GLU THR LEU LEU PRO ARG HIS LEU GLN ILE SEQRES 31 A 830 ILE TYR GLU ILE ASN GLN ARG PHE LEU ASN ARG VAL ALA SEQRES 32 A 830 ALA ALA PHE PRO GLY ASP VAL ASP ARG LEU ARG ARG MET SEQRES 33 A 830 SER LEU VAL GLU GLU GLY ALA VAL LYS ARG ILE ASN MET SEQRES 34 A 830 ALA HIS LEU CYS ILE ALA GLY SER HIS ALA VAL ASN GLY SEQRES 35 A 830 VAL ALA ARG ILE HIS SER GLU ILE LEU LYS LYS THR ILE SEQRES 36 A 830 PHE LYS ASP PHE TYR GLU LEU GLU PRO HIS LYS PHE GLN SEQRES 37 A 830 ASN LYS THR ASN GLY ILE THR PRO ARG ARG TRP LEU VAL SEQRES 38 A 830 LEU CYS ASN PRO GLY LEU ALA GLU ILE ILE ALA GLU ARG SEQRES 39 A 830 ILE GLY GLU GLU TYR ILE SER ASP LEU ASP GLN LEU ARG SEQRES 40 A 830 LYS LEU LEU SER TYR VAL ASP ASP GLU ALA PHE ILE ARG SEQRES 41 A 830 ASP VAL ALA LYS VAL LYS GLN GLU ASN LYS LEU LYS PHE SEQRES 42 A 830 ALA ALA TYR LEU GLU ARG GLU TYR LYS VAL HIS ILE ASN SEQRES 43 A 830 PRO ASN SER LEU PHE ASP VAL GLN VAL LYS ARG ILE HIS SEQRES 44 A 830 GLU TYR LYS ARG GLN LEU LEU ASN CYS LEU HIS VAL ILE SEQRES 45 A 830 THR LEU TYR ASN ARG ILE LYS LYS GLU PRO ASN LYS PHE SEQRES 46 A 830 VAL VAL PRO ARG THR VAL MET ILE GLY GLY LYS ALA ALA SEQRES 47 A 830 PRO GLY TYR HIS MET ALA LYS MET ILE ILE LYS LEU ILE SEQRES 48 A 830 THR ALA ILE GLY ASP VAL VAL ASN HIS ASP PRO VAL VAL SEQRES 49 A 830 GLY ASP ARG LEU ARG VAL ILE PHE LEU GLU ASN TYR ARG SEQRES 50 A 830 VAL SER LEU ALA GLU LYS VAL ILE PRO ALA ALA ASP LEU SEQRES 51 A 830 SER GLU GLN ILE SER THR ALA GLY THR GLU ALA SER GLY SEQRES 52 A 830 THR GLY ASN MET LYS PHE MET LEU ASN GLY ALA LEU THR SEQRES 53 A 830 ILE GLY THR MET ASP GLY ALA ASN VAL GLU MET ALA GLU SEQRES 54 A 830 GLU ALA GLY GLU GLU ASN PHE PHE ILE PHE GLY MET ARG SEQRES 55 A 830 VAL GLU ASP VAL ASP ARG LEU ASP GLN ARG GLY TYR ASN SEQRES 56 A 830 ALA GLN GLU TYR TYR ASP ARG ILE PRO GLU LEU ARG GLN SEQRES 57 A 830 ILE ILE GLU GLN LEU SER SER GLY PHE PHE SER PRO LYS SEQRES 58 A 830 GLN PRO ASP LEU PHE LYS ASP ILE VAL ASN MET LEU MET SEQRES 59 A 830 HIS HIS ASP ARG PHE LYS VAL PHE ALA ASP TYR GLU GLU SEQRES 60 A 830 TYR VAL LYS CYS GLN GLU ARG VAL SER ALA LEU TYR LYS SEQRES 61 A 830 ASN PRO ARG GLU TRP THR ARG MET VAL ILE ARG ASN ILE SEQRES 62 A 830 ALA THR SER GLY LYS PHE SER SER ASP ARG THR ILE ALA SEQRES 63 A 830 GLN TYR ALA ARG GLU ILE TRP GLY VAL GLU PRO SER ARG SEQRES 64 A 830 GLN ARG LEU PRO ALA PRO ASP GLU LYS ILE PRO HET PLP A 999 15 HET CHI A 920 31 HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETNAM CHI 5-CHLORO-1H-INDOLE-2-CARBOXYLIC ACID [1-(4- HETNAM 2 CHI FLUOROBENZYL)-2-(4-HYDROXYPIPERIDIN-1YL)-2- HETNAM 3 CHI OXOETHYL]AMIDE HETSYN PLP VITAMIN B6 PHOSPHATE FORMUL 2 PLP C8 H10 N O6 P FORMUL 3 CHI C23 H23 CL F N3 O3 FORMUL 4 HOH *256(H2 O) HELIX 1 1 GLY A 20 THR A 38 1 19 HELIX 2 2 THR A 47 ASP A 78 1 32 HELIX 3 3 THR A 94 ASN A 101 1 8 HELIX 4 4 LEU A 104 LEU A 115 1 12 HELIX 5 5 ASP A 118 GLU A 124 1 7 HELIX 6 6 GLY A 134 LEU A 150 1 17 HELIX 7 7 PRO A 194 THR A 197 5 4 HELIX 8 8 ASP A 251 ASP A 256 1 6 HELIX 9 9 GLY A 261 ASP A 268 1 8 HELIX 10 10 ALA A 272 ARG A 277 5 6 HELIX 11 11 LYS A 289 SER A 314 1 26 HELIX 12 12 ASN A 325 ASP A 327 5 3 HELIX 13 13 ALA A 328 LYS A 332 1 5 HELIX 14 14 LEU A 344 LEU A 356 1 13 HELIX 15 15 ASP A 360 THR A 371 1 12 HELIX 16 16 ILE A 380 LEU A 384 5 5 HELIX 17 17 VAL A 389 LEU A 396 1 8 HELIX 18 18 LEU A 396 PHE A 418 1 23 HELIX 19 19 ASP A 421 SER A 429 1 9 HELIX 20 20 MET A 441 GLY A 448 1 8 HELIX 21 21 ALA A 456 THR A 466 1 11 HELIX 22 22 PHE A 468 GLU A 475 1 8 HELIX 23 23 ASN A 496 GLY A 508 1 13 HELIX 24 24 GLU A 509 ASP A 514 5 6 HELIX 25 25 ASP A 514 VAL A 525 5 12 HELIX 26 26 ASP A 527 TYR A 553 1 27 HELIX 27 27 ARG A 575 GLU A 593 1 19 HELIX 28 28 TYR A 613 ASN A 631 1 19 HELIX 29 29 ARG A 649 ILE A 657 1 9 HELIX 30 30 PRO A 658 ALA A 660 5 3 HELIX 31 31 THR A 676 ASN A 684 1 9 HELIX 32 32 ALA A 695 GLY A 704 1 10 HELIX 33 33 GLU A 705 PHE A 708 5 4 HELIX 34 34 ARG A 714 GLY A 725 1 12 HELIX 35 35 ASN A 727 ILE A 735 1 9 HELIX 36 36 ILE A 735 SER A 747 1 13 HELIX 37 37 PHE A 758 HIS A 768 1 11 HELIX 38 38 VAL A 773 ALA A 775 5 3 HELIX 39 39 ASP A 776 LYS A 792 1 17 HELIX 40 40 ASN A 793 ALA A 806 1 14 HELIX 41 41 THR A 807 PHE A 811 5 5 HELIX 42 42 SER A 812 ILE A 824 1 13 SHEET 1 A 9 PHE A 479 ASN A 481 0 SHEET 2 A 9 VAL A 452 GLY A 454 1 O VAL A 452 N GLN A 480 SHEET 3 A 9 CYS A 372 THR A 375 1 O TYR A 374 N ASN A 453 SHEET 4 A 9 VAL A 333 ASN A 338 1 O ILE A 335 N ALA A 373 SHEET 5 A 9 ARG A 81 LEU A 85 1 O ARG A 81 N ALA A 334 SHEET 6 A 9 ALA A 154 ILE A 159 1 O TYR A 155 N TYR A 84 SHEET 7 A 9 VAL A 238 LYS A 247 1 O THR A 240 N GLY A 156 SHEET 8 A 9 GLN A 219 PRO A 231 -1 N LEU A 222 O LYS A 247 SHEET 9 A 9 LYS A 191 ALA A 192 -1 O LYS A 191 N ASP A 227 SHEET 1 A1 9 PHE A 479 ASN A 481 0 SHEET 2 A1 9 VAL A 452 GLY A 454 1 O VAL A 452 N GLN A 480 SHEET 3 A1 9 CYS A 372 THR A 375 1 O TYR A 374 N ASN A 453 SHEET 4 A1 9 VAL A 333 ASN A 338 1 O ILE A 335 N ALA A 373 SHEET 5 A1 9 ARG A 81 LEU A 85 1 O ARG A 81 N ALA A 334 SHEET 6 A1 9 ALA A 154 ILE A 159 1 O TYR A 155 N TYR A 84 SHEET 7 A1 9 VAL A 238 LYS A 247 1 O THR A 240 N GLY A 156 SHEET 8 A1 9 GLN A 219 PRO A 231 -1 N LEU A 222 O LYS A 247 SHEET 9 A1 9 LEU A 198 PHE A 202 -1 O LEU A 198 N ALA A 223 SHEET 1 B 2 PHE A 89 GLY A 92 0 SHEET 2 B 2 ALA A 129 LEU A 131 -1 O ALA A 129 N GLY A 92 SHEET 1 C 2 ASN A 167 CYS A 171 0 SHEET 2 C 2 TRP A 174 GLU A 178 -1 O TRP A 174 N CYS A 171 SHEET 1 D 2 ARG A 205 HIS A 208 0 SHEET 2 D 2 ALA A 213 VAL A 216 -1 O LYS A 214 N GLU A 207 SHEET 1 E 3 ARG A 386 PRO A 388 0 SHEET 2 E 3 ARG A 438 ASN A 440 -1 N ILE A 439 O TRP A 387 SHEET 3 E 3 VAL A 431 GLU A 432 -1 N GLU A 432 O ARG A 438 SHEET 1 F 6 LEU A 640 LEU A 645 0 SHEET 2 F 6 ARG A 601 GLY A 606 1 O ARG A 601 N ARG A 641 SHEET 3 F 6 LEU A 562 VAL A 567 1 O LEU A 562 N THR A 602 SHEET 4 F 6 LEU A 662 GLN A 665 1 O LEU A 662 N VAL A 565 SHEET 5 F 6 LEU A 687 GLY A 690 1 O LEU A 687 N SER A 663 SHEET 6 F 6 PHE A 709 ILE A 710 1 N PHE A 709 O THR A 688 LINK NZ LYS A 680 C4A PLP A 999 1555 1555 1.33 SITE 1 HPP 3 ARG A 60 VAL A 64 LYS A 191 SITE 1 AC1 16 GLY A 134 TRP A 491 LYS A 568 LYS A 574 SITE 2 AC1 16 TYR A 648 ARG A 649 VAL A 650 GLY A 675 SITE 3 AC1 16 THR A 676 GLY A 677 LYS A 680 HOH A1058 SITE 4 AC1 16 HOH A1112 HOH A1113 HOH A1117 HOH A1124 SITE 1 AC2 16 THR A 38 VAL A 40 PHE A 53 HIS A 57 SITE 2 AC2 16 ARG A 60 VAL A 64 TRP A 67 GLY A 186 SITE 3 AC2 16 ASN A 187 PRO A 188 TRP A 189 GLU A 190 SITE 4 AC2 16 LYS A 191 ALA A 192 HOH A1091 HOH A1158 CRYST1 129.174 127.174 116.220 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007741 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007863 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008604 0.00000